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Objective: This study was conducted to identify the safety of endovascular procedures in the ofﬁce endovascular suite and
to assess patient satisfaction in this setting.
Methods: Between May 22, 2007, and December 31, 2012, 2822 patients underwent 6458 percutaneous procedures in an
ofﬁce-based endovascular suite. Demographics of the patients, complications, hospital transfers, and 30-day mortality
were documented in a prospective manner. Follow-up calls were made, and a satisfaction survey was conducted. Almost
all dialysis procedures were done under local anesthesia and peripheral arterial procedures under conscious sedation.
All patients, except those undergoing catheter removals, received hydrocodone and acetaminophen (5/325 mg), diaz-
epam (5-10 mg), and one dose of an oral antibiotic preprocedure and three doses postprocedure. Patients who required
conscious sedation received fentanyl and midazolam. Conscious sedation was used almost exclusively in patients having an
arterial procedure. Measurements of blood urea nitrogen, creatinine, international normalized ratio, and partial
thromboplastin time were performed before peripheral arteriograms. All other patients had no preoperative laboratory
tests. Patients considered high risk (American Society of Anesthesiologists Physical Status Classiﬁcation 4), those who
could not tolerate the procedure with mild to moderate conscious sedation, patients with a previous bad experience, or
patients who weighed >400 pounds were not candidates for ofﬁce based procedures.
Results: There were 54 total complications (0.8%): venous, 2.2%; aortogram without interventions, 1%; aortogram with
interventions, 2.7%; ﬁstulogram, 0.5%; catheters, 0.3%; and venous ﬁlter-related, 2%. Twenty-six patients required
hospital transfer from the ofﬁce. Ten patients needed an operative intervention because of a complication. No procedure-
related deaths occurred. There were 18 deaths in a 30-day period. Of patients surveyed, 99% indicated that they would
come back to the ofﬁce for needed procedures.
Conclusions:When appropriately screened, almost all peripheral interventions can be performed in the ofﬁce with minimal
complications. For dialysis patients, outpatient intervention has a very low complication rate and is the mainstay of
treatment to keep the dialysis access patent. Venous insufﬁciency, when managed in the ofﬁce setting, also has a low
complication rate. Ofﬁce-based procedural settings should be seriously considered for percutaneous interventions for
arterial, venous, and dialysis-related procedures. (J Vasc Surg 2014;59:186-91.)Ofﬁce-based endovascular centers are being opened As the conﬁdence in providing intervention has
throughout the country, partly due to the Deﬁcit Reduc-
tion Act of 2005 and the development of endovascular
techniques. These centers have opened because of multiple
reasons, the ﬁrst being convenience for the patient, along
with ease of scheduling cases for the doctor and better
reimbursement for physicians because technical compo-
nents can be billed in addition to the professional compo-
nent. Despite more than 100 centers currently operating in
United States, there is dearth of data about the use of these
centers and the safety of procedures. Most units were
opened to provide outpatient management of dialysis
access and that is why many facilities are called “access
centers.” Predating these were ofﬁce-based venous centers
that treated patients with venous insufﬁciency.Advanced Vascular Surgery.
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arterial and other procedures are being carried out in
this setting. In 2008, Samson1 recommended adding an
angiography suite to the vascular laboratory. It has been
shown that there are savings in overall health expenditures
when the procedure is done in the ofﬁce setting compared
with the hospital.2 The savings to Medicare in 1 year was
>$800,000.00 when the cases were performed in the
ofﬁce.
Multiple questions that remain unanswered include:
1. Is it safe to provide this service in the ofﬁce?
2. Are the patients satisﬁed?
3. What is the short-term, medium-term, and long-
term efﬁcacy when procedures are done in the ofﬁce
compared with the hospital?
In this report we look at the safety of the procedures
done in the ofﬁce along with patient satisfaction.
METHODS
After 1 year of planning, our center opened on May 22,
2007, as described in a previous article.2 One of the
surgeons is a designated medical director. Data were
prospectively entered in Access software (Microsoft Corp,
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dures performed until December 31, 2012. Demographic
data and risk factors (diabetes, hypertension, smoking,
and hyperlipidemia) were collected. Procedure-related
complications, transfer to the hospital, and subsequent
outcomes were documented. Mortality data at 30 days
were collected retrospectively.
All registered nurses and physicians are certiﬁed in
Advance Cardiac Life Support. For conscious sedation,
hospital guidelines adapted for the ofﬁce are followed.
Triage criteria have evolved to identify patients not suitable
for an ofﬁce procedure: weight >400 pounds, American
Society of Anesthesiologists Physical Status Classiﬁcation
4, those with a history of contrast anaphylaxis, those who
require general anesthesia, and those with a previous bad
experience. Patients who are already admitted to the
hospital undergo the procedure in the hospital.
Thirty minutes before the procedure, all patients,
except those undergoing catheter removal, received
hydrocodone and acetaminophen (5/325 mg), diazepam
(5-10 mg), and cephalexin (500 mg; one dose preproce-
dure and three doses postprocedure). In patients with peni-
cillin or cephalexin allergy, clindamycin (300 mg) was
substituted. Fasting is only required for conscious sedation.
Conscious sedation patients were given an antibiotic pre-
procedure and midazolam and fentanyl during the proce-
dure. Conscious sedation was almost exclusively used for
arterial procedures. Occasionally during dialysis or a venous
procedure, fentanyl was given through the catheter already
in the vessel if patient was having severe discomfort.
Preprocedure assays for blood urea nitrogen, creatinine,
prothrombin time, and partial thromboplastin time were ob-
tained for patients undergoing arterial procedures. No labo-
ratory studies were done in any other category of patients.
No postoperative laboratory studies were performed.
Patients with a glomerular ﬁltration rate of <60 mL/min/
1.73 m2 were hydrated before an arteriogram.
Diagnostic arterial procedures were performed using
4F catheters, almost always through a femoral approach,
although we occasionally used brachial or radial approaches.
When intervention was required, appropriately sized cathe-
ters were used, 6F being the commonest. Closure devices
were used by operator preference. Access to the artery
was always obtained using ultrasound guidance. Rotation
atherectomy was done using a Stealth 360 catheter
(Cardiovascular Systems Inc, St. Paul, Minn).
Clopidogrel was started after the intervention accord-
ing to operator preference. Most patients received
30 days of antiplatelet treatment with clopidogrel and
indeﬁnite treatment with aspirin, if tolerated. Clopidogrel
was not given before the procedure to decrease the inci-
dence of bleeding and not knowing if intervention would
be completed.
A ﬁstulogram was carried out if one of the following
criteria were met: (1) rising venous pressure as identiﬁed
by the dialysis unit, (2) 15% increase in recirculation, (3)
graft blood ﬂow of <600 mL/min, (4) Doppler ultrasound
imaging showing >70% stenosis, (5) increased bleedingfrom the needle site, or (6) ﬁstula not maturing. Routine
ﬁstulograms at ﬁxed intervals and balloon-assisted matura-
tion3 of the ﬁstula were not carried out.
The ﬁstulogram was generally performed through 4F
sheaths that were upsized to 5F or 6F for balloon interven-
tions. Covered stents, when used, were placed “bare back”
to avoid a large sheath size. Thrombectomy procedures
were done with two sheaths with intra-access tissue plas-
minogen activator and balloon-assisted clot maceration/
retrieval.4 Hemostasis was achieved with manual pressure
or nylon suture.
For patients receiving dialysis, data were collected from
the hospital and ofﬁce to calculate procedures performed
per patient per year. These included all procedures per-
formed to maintain a functional dialysis ﬁstula or graft or
temporary catheter access for each patient.
For venous insufﬁciency, endovenous laser therapy
(EVLT) using a Dornier (Dornier, Wessling, Germany)
940-diode laser wavelength was done under tumescent
anesthesia. Radiofrequency ablation was used in seven cases
while evaluating the machine. Microphlebectomy was
carried out in a standard manner under local anesthesia.
Within 7 to 10 days, venous ultrasound scanning was
done to assess the success of the procedure and identify
possible deep vein thrombosis (DVT). Sclerotherapy,
which was done by a registered certiﬁed nurse under physi-
cian supervision, is not included in this report because most
of these procedures were carried out for cosmetic reasons.
Venograms were performed for dialysis patients or
for chronic venous insufﬁciency of the legs. PowerPorts
(Bard Access Systems Inc, Salt Lake City, Utah) were
placed in cancer patients and removed when no longer
needed. Inferior cava ﬁlters were placed for elective indica-
tions. Retrievable ﬁlters were removed in the ofﬁce after
patient was discharged from the hospital and the risk of
DVT or pulmonary embolism was minimal.
In the ﬁrst 2 years of opening the center, an attempt
was made to call every patient the next day after the proce-
dure. Now, 10% of the patients are called at random
by ofﬁce staff, which is done to avoid bias and is represen-
tative of the procedures done in the ofﬁce (ie, patients
undergoing different types of procedures are called).
Patients are asked if the experience was satisfactory and if
they would come back to the center if a procedure were
needed in the future. Every patient is followed up in the
ofﬁce in the postprocedural period. Any complication is
documented.
RESULTS
During the study period, 2822 patients, 1474 females
(52%) and 1348 males (48%), underwent 6458 procedures.
There were 2398 Caucasians (85%), 357 African Americans
(13%), 56 Hispanics (2%), and 11 others (<1%). Patients
were an average age of 61 years (range, 15-94 years).
Comorbidities included hypertension in 1750 (62%),
hyperlipidemia in 1492 (53%), diabetes in 950 (34%),
and nicotine addiction in 448 (16%). More than two
comorbidities were present in 1600 patients (57%).
Table I. Total procedures by type
Procedure No. (%)
Fistulograms
Fistulogramdangioplasty 1704 (63)
Fistulogramdthrombectomydangioplasty 582 (21)
Fistulogram 260 (10)
Fistulogramdangioplastydcoiling 51 (2)
Fistulogramdcoiling 47 (2)
Fistulogramdangioplastydstent 45 (1)
Fistulogramdthrombectomydangioplastydstent 26 (1)
Fistulogramdthrombectomy 2 (<1)
Fistulogramdangioplastydcoilingdstent 1 (<1)
Fistulogramdstent 1 (<1)
Aortograms
Aortogram, runoff 498 (53)
Aortogram, runoff, angioplasty 234 (25)
Aortogram 73 (8)
Aortogram, runoff, angioplasty, stent 61 (6)
Atherectomy 45 (5)
Aortogram, runoff, stent 21 (2)
Aortogram, angioplasty, stent 2 (<1)
Cerebral angiogram 5 (<1)
Catheters
Removal 773 (52)
Insertion 410 (28)
Exchange 291 (20)
Cathetergram 3 (<1)
Venous
EVLTdmicrophlebectomy 512 (50)
EVLT 390 (38)
Microphlebectomy 110 (11)
Radiofrequency ablation 4 (<1)
Radiofrequency ablationdmicrophlebectomy 3 (<1)
Venograms
Venogram 55 (87)
Venogramdangioplasty 7 (11)
Venogramdangioplastydstent 1 (2)
PowerPortsa
Insertion 148 (80)
Removal 31 (17)
Exchange 4 (2)
PowerPortgram 1 (<1)
Inferior vena cava ﬁlters
Filter removal 47 (82)
Filter placement 10 (18)
Total 6458 (100)
EVLT, Endovenous laser ablation.
aBard Access Systems Inc, Salt Lake City, Utah.
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carried out most frequently, followed by catheter-related
cases (23%), venous cases (16%), arteriograms (15%),
power ports (3%), venograms (1%), and venacaval ﬁlter-
related procedures (1%; Table I). Distribution of complica-
tions is listed in Table II. Arterial procedures with
intervention had the highest complication rate (10 of
368 [2.7%]), followed by venous procedures (22 of 1019
[2.2%]). Arteriogram patients without intervention had
three site-related bleeding complications and one throm-
bosis of a leg bypass (four of 571 [1%]). In the category
of arteriogram with intervention, there were 6 bleeding
complications, 2 episodes of hypotension, 1 cellulitis, and
1 thrombosis of the superﬁcial femoral artery. Complica-
tions in the category of venous EVLT, with or without
microphlebectomy, included thrombus involving the
saphenofemoral junction in 7, DVT in 7, cellulitis in 5,
and ulcers in 3. In the category of ﬁstulogram, with or
without intervention, bleeding occurred in 3, cardiac
arrhythmia in 3, cellulitis in 2, dye reaction in 1, entrapped
wire in 1, arterial embolization in 1, seizure in 1, and
syncope in 1. In the category of tunneled catheter, there
was 1 injured carotid, 1 bleeding complication, 1 infection,
and 1 patient with dyspnea. In the inferior vena cava ﬁlter
patients, one had arrhythmia.
Twenty-six procedures (0.4%) required patient transfer
to the hospital. The reasons for transfer are listed in
Table III. The commonest cause of transfer was bleeding.
Nine of the 26 patients transferred to the hospital had
an operative intervention. Six of 939 arterial procedures
(0.6%) had complications requiring operation. Three
patients underwent repair of the access artery, and one
patient each had thrombectomy, revision of a leg bypass,
and drainage of a hematoma. None of the bleeding
complications were life-threatening or limb-threatening.
One more patient with a planned open operation was
found to have occlusion of a femoral-anterior tibial bypass,
was admitted 2 days after the procedure, and successfully
treated.
Three of 2719 patients (0.1%) had an operation after
a dialysis procedure. In one patient, an 0.18-inch wire
became stuck during the procedure and curled in the graft
and could not be retrieved. The patient underwent success-
ful thrombectomy and wire removal. One patient under-
went ligation of a ruptured vein and interposition graft.
One patient had thrombectomy of the graft and embolec-
tomy of distal artery. This patient in long-term follow up
had phalangectomy from distal embolization.
In 2010, we performed 2.62 procedures per dialysis
patient per year, followed by 2.16 procedures in 2011
and 1.93 procedures in 2012 (Table IV). These included
all procedures carried out in the hospital and ofﬁce for all
patients to continue to have access for hemodialysis after
the initial ﬁstula creation.
There were 18 deaths in the 30-day period after the
procedure (Fig). There were no procedure-related deaths
in 12 patients when a cause of death could be ascertained.
Sixteen of these patients were dialysis-dependant. Most ofthe deaths were related to chronic disease. The cause of
death in six patients could not be ascertained from hospital
records or by family contact. One patient died of lung
cancer after port placement. One patient died of myocar-
dial infarction during a cardiac workup before an open
vascular procedure after peripheral arteriogram.
Of the 1096 patients who underwent an ofﬁce proce-
dure, 1085 (99%) were satisﬁed and would come back if
another procedure were needed. According to our ofﬁce
triage criteria, 4% of our dialysis patients could not have
intervention in the ofﬁce setting. During the same period,
2284 endovascular procedures (1871 inpatient, 413 outpa-
tient) were completed in the hospital, excluding venous
procedures, because all of these are carried out in the ofﬁce.
Table II. Patient complications and procedures
Procedure type Procedures, No. Patients, No. Complications, No.
Complications per
Procedure, % Patient, %
Venous 1019 785 22 2.20 2.80
Aortogram
No interventions 571 464 4 1 1
With interventions 368 191 10 2.70 5.20
Fistulogram 2719 829 13 0.50 1.60
Catheters 1477 342 4 0.30 1.20
Inferior vena cava ﬁlters 57 24 1 2 4.20
Table III. Patients transferred to the hospital
Complication No. Transfer, %
Hematoma 9 34.50
Thrombosis 3 11.50
Cardiac 3 11.50
Pseudoaneurysm 2 7.70
Hypotension 2 7.70
Syncope 2 7.70
Hypoxia 1 3.80
Seizure 1 3.80
Bleeding 1 3.80
Dyspnea 1 3.80
Irretrievable wire 1 3.80
Total 26
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As the cost of providing care to patients continues to
escalate, physicians have to innovate and look at alternative
ways to deliver high-quality care. Almost all endovascular
procedures have traditionally been performed in the
hospital. With the advent of endovenous ablation for the
saphenous vein, physicians started to get comfortable
offering invasive procedures in the ofﬁce. Once the Center
for Medicare and Medicaid Services began paying for endo-
vascular procedures in the ofﬁce, other insurance carriers
followed suit.
Despite several thousand procedures being carried in
the ofﬁce at various centers every year, data on the safety
and efﬁcacy of some of these procedures are lacking. The
vascular surgeons carrying out these procedures are taking
the skill set they use in the hospital to their ofﬁces, so one
would expect similar outcomes. Most of the comparative
data, except for venous procedures, are from the hospital
experience. Basic principles of safety apply to all proce-
dures. However, because the procedures are very different
from each other, we examined each category of proce-
dures separately and compared the results with the avail-
able data.
Fistulograms. The commonest procedure performed
in the endovascular suite is related to maintaining arteriove-
nous access. Numerous prospective and retrospective studies
have tried to determine the effectiveness of intervention with
respect to access longevity.5-15 Results are mixed. However,most studies were limited by sample size, heterogeneous
study groups, and differing end points. We and others have
previously shown that access thrombosis is almost always the
result of outﬂow stenosis, so monitoring for access failure
and in-ofﬁce correction should minimize missed dialysis
sessions and lead to fewer catheters.4,16 Studies have sug-
gested that balloon-assisted maturation of the ﬁstula may
be beneﬁcial.3 We are still waiting to see more studies to
conﬁrm this approach before we start using it.
We believe that ofﬁce-based approach is valid because
our reintervention rates and access longevity compare
favorably with those in the literature.17 We believe that
this rate of success can be reached only by a dedicated
team at the endovascular center headed by the surgeons
who create the access and maintain it. A close relationship
with the nephrologists and the dialysis units is crucial, and
a nurse practitioner coordinator is of great help.
Catheters. Only four complications occurred in 1477
catheter-related procedures (0.3%). None of the compli-
cations resulted in an operative intervention. We believe
ultrasound guidance is a valuable asset in establishing safe
central venous access. The catheter is removed by the nurse
practitioner under physician supervision.
Aortograms and interventions. In the initial period,
very few peripheral procedures were carried out in the ofﬁce.
We gradually started with aortograms and subsequently
added peripheral interventions. Rotational atherectomy was
added to the armamentarium last year. There are data in
the literature supporting same-day discharge after periph-
eral or coronary interventions done in the hospital.18-23 To
the best of our knowledge, no data have been published
relating to ofﬁce-based arterial interventions. Our compli-
cation rates of 1% in the aortogram group and 2.7% in the
intervention group are comparable to those cited above.
Stenting after angioplasty is performed selectively. This may
help minimize sheath size and possible bleeding risk. The
center also stocks covered stents for bail-out procedures.
Venous procedures. Most vascular surgeons do
venous procedures in ofﬁce-based venous centers. We have
incorporated a venous center into our endovascular suite to
increase productivity, efﬁciency, and cost-effectiveness. Our
complication rate of 2.2% in patients undergoing EVLT and
EVLT and microphlebectomy is comparable with most
published series.24,25 In these two groups, the combined
Table IV. Annual procedures per dialysis patient
Year Dialysis patients, No.
Procedures Procedures per patient
Ofﬁce, No. Hospital, No. Total, No. Ofﬁce, No. Hospital, No. Total, No.
2010 405 754 308 1062 1.86 0.76 2.62
2011 578 895 352 1247 1.55 0.61 2.16
2012 625 881 326 1207 1.41 0.52 1.93
Fig. The total number of deaths and the cause of death in the group are shown.
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was also 0.8%. There were no pulmonary embolisms. Total
incidence of venous thrombosis requiring treatment was
1.6%. Myers and Jolley24 noted a 3% incidence of throm-
boembolic complications, and Knipp et al25 reported a DVT
rate of 2.2% and saphenous vein encroachment in 5.9% in
patients undergoing EVLT and microphlebectomy. In the
same series, when EVLT was performed alone, the DVT
rate was 0% and encroachment was found in 7.8%. Use of
EVLT and radiofrequency ablation is well established in
the ofﬁce setting. These procedures are rarely performed in
the hospital.
Other procedures. Other procedures, including veno-
grams and port placements, are routinely performed in the
outpatient radiology setting. We documented no complica-
tions in this category of patients. Most intracaval ﬁlters are
placed in the hospital for acute conditions. One patient
developed cardiac arrhythmia and required transfer to the
hospital. With the advent of retrievable ﬁlters, most of
the ﬁlters placed by our service, whether inpatient or not,
are retrieved in the ofﬁce. No complications occurred in
this small subgroup.
Hospital transfers. Every nurse and physician at the
center is certiﬁed in Advance Cardiac Life Support. We
use conscious sedation judiciously, accounting for the age
and comorbidities of our patients. Despite all precautions,
urgent transfer to the hospital is sometimes needed. The
commonest causes for transfer were bleeding and cardiac
complications. Covered stents are kept in the ofﬁce in
case of vessel ruptures. There is a protocol to manage these
emergencies. A covered stent is used if indicated,resuscitative measures are taken, and 911 is called to trans-
fer the patient to the hospital where we have privileges. As
appropriate hemodynamic support is provided, the ambu-
lance service is called to transfer the patient to the hospital
emergency department. There were no deaths as a result of
these complications.
Patient satisfaction. When patients are appropriately
screened, there is a very high satisfaction rate in the ofﬁce
setting. We believe the main reason for this is the patient’s
familiarity with the staff and surgeons. The process of
checking in and out is very simple and quick. No tests
are performed or visits required before the procedure,
except in the arteriogram category, when one visit is
made to the laboratory. Services are provided in a timely
manner. Fasting is not required unless conscious sedation
is used, which simpliﬁes diabetic management. Dialysis
patients receive continuum of care between dialysis staff,
nephrologists, the nurse practitioner coordinator, endovas-
cular suite staff, and vascular surgeons. The main reason
patients are dissatisﬁed is because of poor pain control or
anxiety. This occurs mainly in the dialysis patients who
are not treated with conscious sedation. Better patient
satisfaction in this group could potentially be obtained by
offering conscious sedation to them as well. However,
these are generally sicker patients, which increases the risk
of complications. Establishing preprocedure venous access
in chronic hemodialysis patients can also be very chal-
lenging. A telephone survey was carried out because our
dialysis-dependant patient population is unreliable in
returning a more comprehensive paper survey. A compre-
hensive survey would be more desirable, which should
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 1 Jain et al 191include the patient experience if the patient had a similar
procedure in the hospital.
Because an increasing number of cases are performed
in physicians’ ofﬁces, a registry is needed to gather data
for analysis of the indications and outcomes. There are
no data dealing with medium-term and long-term results
of peripheral arterial and dialysis access interventions in
the ofﬁce. We suspect that with similar patient satisfaction
and good patient safety in either setting, a prospective
study comparing hospital-based with ofﬁce-based proce-
dures would be difﬁcult to carry out due to the high enroll-
ment required. Now that we have several years of
experience in the ofﬁce setting, we are looking at our
long-term outcomes and will publish the data in the future.
CONCLUSIONS
With a large experience being reported, we believe that
a variety of procedures can be performed safely in an ofﬁce
endovascular suite. For patients on dialysis, outpatient
procedures are the mainstay of treatment to keep the access
functioning and to manage catheters. After appropriate
screening, patients with peripheral arterial disease in the
extremities can be managed in the ofﬁce if an endovascular
procedure is indicated. The ofﬁce is the ideal place to carry
out venous procedures to manage venous insufﬁciency and
varicose veins. The ofﬁce endovascular suite should be the
preferred site for all percutaneous dialysis and venous
procedures and for a majority of arterial procedures.
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